Substantiation of the National Policy of Pricing and Availability of Drugs

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.2781
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Pricing of Breakthrough Drugs: Theory and Policy Implications

PLoS ONE
Multidisciplinary
2014English

Agricultural Pricing and Structural Policy I: Macro-Aspects of Pricing Policy

Agrekon
DevelopmentEconomicsCrop SciencePlanningAgronomyEconometricsGeography
1982English

Pricing Drugs

Health Affairs
MedicineHealth Policy
2003English

Drugs and Drug Policy: The Control of Consciousness Alteration Drugs and Drug Policy: The Control of Consciousness Alteration

2007English

Availability, Pricing and Affordability of Selected Medicines for Noncommunicable Diseases

Eastern Mediterranean Health Journal
Medicine
2019English

Pricing and Reimbursement of Orphan Drugs: The Need for More Transparency

Orphanet Journal of Rare Diseases
MedicineGeneticsPharmacology
2011English

Psy147 - Availability and Reimbursement of Orphan Drugs in the Czech Republic

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Transfer Pricing and the Czech Tax Policy

Acta Universitatis Agriculturae et Silviculturae Mendelianae Brunensis
AgriculturalBiological Sciences
2010English

The Impact of Generic Drug Policy on Drug Pricing

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy